MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model.

Authors: Bębenek, Wiktoria^1,2 (AUTHOR) wiktoria.bebenek@edu.uni.lodz.pl, Gajek, Arkadiusz¹ (AUTHOR) arkadiusz.gajek@biol.uni.lodz.pl, Marczak, Agnieszka¹ (AUTHOR) agnieszka.marczak@biol.uni.lodz.pl, Malý, Jan³ (AUTHOR) jan.maly@ujep.cz, Smejkal, Jiří³ (AUTHOR) jiri.smejkal@ujep.cz, Statkiewicz, Małgorzata⁴ (AUTHOR) malgorzata.statkiewicz@pib-nio.pl, Rusetska, Natalia⁵ (AUTHOR) natalia.rusetska@pib-nio.pl, Bryś, Magdalena⁶ (AUTHOR) magdalena.brys@biol.uni.lodz.pl, Rogalska, Aneta¹ (AUTHOR) aneta.rogalska@biol.uni.lodz.pl

Source: International Journal of Molecular Sciences. Jan2025, Vol. 26 Issue 2, p834. 21p.

Subject Terms: *CHECKPOINT kinase 1, *LIVER cancer, *HEPATOCELLULAR carcinoma, *THERAPEUTICS, *OVARIAN cancer

Evaluation of the role of oxidative stress in the anticancer effects of CHK1 and PARP-1 inhibitors in HepG2 cells: POST-CONFERENCE REPORT.

Authors: BĘBENEK, WIKTORIA, MARCZAK, AGNIESZKA, ROGALSKA, ANETA

Source: Acta Universitatis Lodziensis Folia Biologica et Oecologica; 2024, Vol. 18, p7-8, 2p